Literature DB >> 20646999

Quantitative assessment of peptide-lipid interactions. Ubiquitous fluorescence methodologies.

Pedro M Matos1, Henri G Franquelim, Miguel A R B Castanho, Nuno C Santos.   

Abstract

Peptide-membrane interactions have been gaining increased relevance, mainly in biomedical investigation, as the potential of the natural, nature-based and synthetic peptides as new drugs or drug candidates also expands. These peptides must face the cell membrane when they interfere with or participate in intracellular processes. Additionally, several peptide drugs and drug leads actions occur at the membrane level (e.g., antimicrobial peptides, cell-penetrating peptides and enveloped viruses membrane fusion inhibitors). Here we explore fluorescence spectroscopy methods that can be used to monitor such interactions. Two main approaches are considered, centered either on the peptide or on the membrane. On the first, we consider mainly the methodologies based on the intrinsic fluorescence of the aminoacid residues tryptophan and tyrosine. Regarding membrane-centric approaches, we review methods based on lipophilic probes sensitive to membrane potentials. The use of fluorescence constitutes a simple and sensitive method to measure these events. Unraveling the molecular mechanisms that govern these interactions can unlock the key to understand specific biological processes involving natural peptides or to optimize the action of a peptide drug.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646999     DOI: 10.1016/j.bbamem.2010.07.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Fluorescence spectroscopy and molecular dynamics simulations in studies on the mechanism of membrane destabilization by antimicrobial peptides.

Authors:  Gianfranco Bocchinfuso; Sara Bobone; Claudia Mazzuca; Antonio Palleschi; Lorenzo Stella
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

2.  Using zeta-potential measurements to quantify peptide partition to lipid membranes.

Authors:  João M Freire; Marco M Domingues; Joana Matos; Manuel N Melo; Ana Salomé Veiga; Nuno C Santos; Miguel A R B Castanho
Journal:  Eur Biophys J       Date:  2011-01-13       Impact factor: 1.733

3.  In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.

Authors:  T N Figueira; L M Palermo; A S Veiga; D Huey; C A Alabi; N C Santos; J C Welsch; C Mathieu; B Horvat; S Niewiesk; A Moscona; M A R B Castanho; M Porotto
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  Primary and Secondary Binding of Exenatide to Liposomes.

Authors:  Anja Stulz; Michaela Breitsamer; Gerhard Winter; Heiko Heerklotz
Journal:  Biophys J       Date:  2020-01-03       Impact factor: 4.033

5.  Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells.

Authors:  Bárbara Gomes; Giusepinna Sanna; Silvia Madeddu; Axel Hollmann; Nuno C Santos
Journal:  ACS Infect Dis       Date:  2019-02-28       Impact factor: 5.084

6.  Variations on fibrinogen-erythrocyte interactions during cell aging.

Authors:  Filomena A Carvalho; Sofia de Oliveira; Teresa Freitas; Sónia Gonçalves; Nuno C Santos
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

7.  The pH-sensitive action of cholesterol-conjugated peptide inhibitors of influenza virus.

Authors:  Patrícia M Silva; Marcelo T Augusto; Matteo Porotto; Nuno C Santos
Journal:  Biochim Biophys Acta Biomembr       Date:  2021-09-01       Impact factor: 4.019

8.  The antimetastatic breast cancer activity of the viral protein-derived peptide vCPP2319 as revealed by cellular biomechanics.

Authors:  Filipa D Oliveira; Marco Cavaco; Tiago N Figueira; Javier Valle; Vera Neves; David Andreu; Diana Gaspar; Miguel A R B Castanho
Journal:  FEBS J       Date:  2021-11-07       Impact factor: 5.622

9.  A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.

Authors:  Frederic Vigant; Jihye Lee; Axel Hollmann; Lukas B Tanner; Zeynep Akyol Ataman; Tatyana Yun; Guanghou Shui; Hector C Aguilar; Dong Zhang; David Meriwether; Gleyder Roman-Sosa; Lindsey R Robinson; Terry L Juelich; Hubert Buczkowski; Sunwen Chou; Miguel A R B Castanho; Mike C Wolf; Jennifer K Smith; Ashley Banyard; Margaret Kielian; Srinivasa Reddy; Markus R Wenk; Matthias Selke; Nuno C Santos; Alexander N Freiberg; Michael E Jung; Benhur Lee
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

10.  Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action.

Authors:  Axel Hollmann; Pedro M Matos; Marcelo T Augusto; Miguel A R B Castanho; Nuno C Santos
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.